Stiletto Lift™

Overview

Stiletto Lift™

High heels shift load toward the forefoot, where the metatarsal heads and plantar fat pad help absorb pressure. The name Stiletto Lift™ describes a consultation about that pressure-related discomfort—not an FDA-approved foot procedure. The FDA has not approved dermal filler to increase foot fullness and recommends against that use. A small, open six-month study of 15 adults reported improvement after hyaluronic-acid filler beneath the metatarsal heads, but it does not establish broad safety, ideal dosing or long-term effectiveness.

1. 01Identify the cause of forefoot pain before discussing filler
2. 02Review footwear, metatarsal pads, orthotics and specialist evaluation first
3. 03Explain the FDA status and limited clinical evidence clearly
4. 04Discuss product, injection plane, emergency plan and follow-up if treatment is considered

Prepare

Preparing thoughtfully

A well-planned procedure begins before treatment day.

1. 01Bring the shoes that provoke symptoms and note where, when and how quickly discomfort develops.
2. 02Review diabetes, circulation problems, neuropathy, inflammatory disease, infection, allergies, prior foot procedures and medications that affect bleeding.
3. 03Consider podiatry or orthopedic evaluation when symptoms suggest stress injury, neuroma, arthritis or another structural condition.
4. 04Read the specific filler labeling and discuss that foot augmentation is not an FDA-approved indication.

Procedure

What the procedure addresses

The ball of the foot is a load-bearing system made up of the metatarsal heads, plantar fat pad, skin, nerves, vessels, tendons and supporting ligaments. High heels shift more load toward this region, but pain can also come from callus, stress injury, nerve irritation, arthritis, biomechanics or another diagnosis. The cause should be identified before any injection is considered.

1. 01Examine the forefoot, pressure points, footwear pattern and gait rather than treating pain from the name alone
2. 02Discuss conservative measures—including shoe modification, metatarsal pads, orthotics and activity changes—before an injection pathway

Techniques

How the plan may be tailored

Technique is selected only after examination, goals and safety considerations are aligned.

1. 01Examine the forefoot, pressure points, footwear pattern and gait rather than treating pain from the name alone
2. 02Discuss conservative measures—including shoe modification, metatarsal pads, orthotics and activity changes—before an injection pathway
3. 03If off-label hyaluronic-acid filler is still considered, document the exact product, amount, tissue plane and emergency plan
4. 04Use sterile technique, conservative placement and planned follow-up; needle-free filler devices are not appropriate

Evidence + status

What the evidence can—and cannot—say

This is the chapter the original pamphlet was missing: the regulatory status and the limits of the available research.

1. 01FDA status: Dermal filler is approved for specific facial and hand indications—not for increasing fullness of the feet. FDA consumer guidance recommends against this use.
2. 02Published evidence: One open six-month study included 15 adults with high-heel-related metatarsalgia. It did not include a control group.
3. 03Reported result: Participants reported less pain and longer heel-wearing time at six months, but the study was not large enough to establish broad safety or ideal treatment technique.
4. 04No duration promise: The evidence does not support guaranteeing that a result will last 9–18 months in the foot.
5. 05Informed choice: Product labeling, off-label status, alternatives, emergency planning and the clinician's experience with forefoot anatomy should be discussed before any decision.

Recovery

Healing is a Sequence

The early view is never the final result. Follow-up allows swelling, sensation, scars and contour to be assessed over time.

1. 01Tenderness, pressure, bruising, redness and swelling may occur after injection and can temporarily change walking comfort.
2. 02Avoid high heels and concentrated forefoot pressure until the treating clinician confirms that activity can resume.
3. 03Evidence for this use is limited; duration, maintenance and long-term effects in the foot are not established by robust clinical trials.
4. 04Increasing pain, blanching, cool skin, color change, drainage, fever, numbness or weakness requires prompt medical evaluation.

Risks + alternatives

An informed decision

Every procedure has limitations and alternatives. Consultation should make both clear.

Questions

Questions worth asking

Start with the indication: the precise anatomical or functional finding the procedure is intended to treat—and why that approach fits better than the alternatives.